A Study of RO7239958 to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics in Healthy Volunteers and Participants With Chronic Hepatitis B Virus Infection
Clinical trial NCT03762681 · TERMINATED
Trial details
- NCT number
- NCT03762681
- Sponsor
- Hoffmann-La Roche
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-14
- Primary completion
- 2020-04-06
- Enrollment
- 55
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.